BBA
Baker Bros. Advisors Portfolio holdings
AUM
$10.3B
This Quarter Return
-9.76%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$16.2B
AUM Growth
+$16.2B
(-14%)
Cap. Flow
+$164M
Cap. Flow
% of AUM
1.01%
Top 10 Holdings %
Top 10 Hldgs %
86.32%
Holding
116
New
17
Increased
25
Reduced
19
Closed
6
Top Buys
| 1 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$45.1M |
| 2 |
Acadia Pharmaceuticals
ACAD
|
$44.4M |
| 3 |
Kodiak Sciences
KOD
|
$25.1M |
| 4 |
Madrigal Pharmaceuticals
MDGL
|
$22M |
| 5 |
ALLK
Allakos
ALLK
|
$17.6M |
Top Sells
| 1 |
BOLD
Audentes Therapeutics, Inc
BOLD
|
$48.2M |
| 2 |
Exact Sciences
EXAS
|
$42.9M |
| 3 |
BLCM
Bellicum Pharmaceuticals, Inc.
BLCM
|
$11.4M |
| 4 |
Adaptive Biotechnologies
ADPT
|
$10.3M |
| 5 |
NextCure
NXTC
|
$8.45M |
Sector Composition
| 1 | Healthcare | 98.59% |
